Clinical trials
Phase 1 Melanoma trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 4 |
| 2013 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 11 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| Pfizer | 3 |
| Bristol-Myers Squibb | 2 |
| GlaxoSmithKline | 2 |
| Pierre Fabre Medicament | 2 |
| Seagen Inc. | 2 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Deciphera Pharmaceuticals, LLC | 1 |
| EMD Serono | 1 |
| HiFiBiO Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 33 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Colorectal Neoplasms | 6 |
| Carcinoma, Renal Cell | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Triple Negative Breast Neoplasms | 5 |
| Neoplasm Metastasis | 4 |
| Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.